The results highlighted that ITGA5, PLAU, PLAUR, SERPINE1, TGFB1, and VEGFC presented significant differences on patients’ survival time, revealing that a high expression, rather than a low expression, of these markers correlated with a significantly poorer survival of patients with HNSCC (Figure 4). This evidence concerns the gene PLAU and head and neck squamous cell carcinoma.